Travere Therapeutics Inc (TVTX) — Long-term Investment Intensity
Travere Therapeutics Inc (TVTX) has a Long-term Investment Intensity of 2.1% as of December 2018. Long-term investments of $15.00 Million represent 2.1% of total assets of $709.16 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check TVTX cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Travere Therapeutics Inc Long-term Investment Intensity (2018–2018)
This chart shows how Travere Therapeutics Inc's Long-term Investment Intensity has evolved across 1 annual periods from 2018 to 2018. As of December 2018, the intensity stands at 2.1%, reflecting long-term investments of $15.00 Million against total assets of $709.16 Million USD. Explore TVTX operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Travere Therapeutics Inc (2018–2018)
The table below presents the year-by-year Long-term Investment Intensity for Travere Therapeutics Inc from 2018 to 2018, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see TVTX stock market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 2.1% | $15.00 Million | $709.16 Million | — |